Roland Schmieder
Latest contributions
Interventions for hypertension and heart failure
19 May 2022 – From EuroPCR 2022
View slides and videos on procedures for hypertension and heart failure including observations and outcomes from the RELIEVE-HF roll-in cohort, a novel approach for performing renal denervation, RDN registry of a resistant hypertension multidisciplinary team..
EuroPCR 2022 Hotlines / Late-Breaking Trials in hypertension management: SPYRAL-HTN ON MED, radiance HTN SOLO and TRIO, and more!
17 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in hypertension management! Blood pressure and MACE reductions after renal denervation: 3-year GSR results, patient-level pooled analysis of ultrasound RDN in radiance-HTN SOLO and Trio, and SPYRAL-HTN ON MED 3 year data.
Treatment of uncontrolled hypertension: case-based discussion
19 May 2021 – From EuroPCR 2021
Watch this session if you want to share indications and optimal criteria for patient selection.
This session was originally presented during EuroPCR 2021.
Clinical event reductions in high-risk hypertension patients treated with renal denervation
18 May 2021 – From EuroPCR 2021
Watch this session presented by Roland Schmieder in order to learn about the long-term safety and efficacy of renal denervation in high-risk subgroups from the largest renal denervation data set of real-world patients, to understand how clinical event rates could be reduced following renal denervation as compared...
Future of renal denervation
It has been a year since the most recent sham controlled trials of renal denervation (RDN) were presented at EuroPCR. Join Felix Mahfoud as he talks to Roland Schmieder and Flavio Ribichini about what they have learned since. Find out what has changed in terms of...
RADIANCE-HTN SOLO: six-month results of renal denervation in patients on medications using the ReCor Paradise endovascular ultrasound system in a randomised, blinded, sham-controlled study
23 May 2019 – From EuroPCR 2019
Consult this session to learn all about the latest results from the RADIANCE-HTN SOLO cohort at the 6-month time point to assess efficacy of renal denervation in patients after medication titration.
ON MED, OFF MED, now what? Future of renal denervation
23 May 2019 – From EuroPCR 2019
Consult this session on renal denervation to gain insights on the future of renal denervation and to learn about the latest results of SPYRAL HTN clinical program.
Interventional neuromodulation – Indications beyond hypertension
23 May 2019 – From EuroPCR 2019
Consult this session on interventional neuromodulation to learn more about the importance of sympathetic overactivity in the pathophysiology of heart failure, arrhythmias, and renal insufficiency and appraise the available and upcoming evidence.
What's new in hypertension treatment – An update for interventionists
23 May 2019 – From EuroPCR 2019
Consult this session to discover the updates in hypertension treatment: learn about new devices for hypertension management, how to apply the new hypertension guidelines in clinical practice, and more!
